Ilika CEO Graeme Purdy joined Steve Darling from Proactive to announce that the company has begun shipping prototype Stereax M300 solid-state batteries to customers, marking a significant commercial milestone for the business. The initial shipments represent the first delivery of the M300 product and will be allocated to the 21 customers that currently make up Ilika’s existing order book.
Many of these customers have already evaluated earlier-generation Stereax batteries supplied from Ilika’s UK pilot production line, and the new prototype deliveries are intended to support further validation and system-level integration. In parallel, a portion of the initial M300 batches will be retained by Ilika for its extensive internal testing programme. This programme is designed to generate a broader and more robust body of performance data aligned with demanding use cases, particularly within active implantable medical devices.
Purdy told Proactive that the potential applications for the Stereax M300 span a wide range of implantable and wearable medical technologies. These include powering implanted sensors, neurostimulators, orthopaedic implants, orthodontic wearables, and ophthalmology devices. He explained that Stereax’s small footprint, combined with enhanced charging capability, makes it especially well suited for AIMDs.
Key benefits of the Stereax technology include reduced surgical time, greater flexibility in placing implants closer to the point of therapy, long operational life, and the convenience of user recharging at home. In addition, the battery’s ability to support Bluetooth radio functionality opens the door to advanced connected medical applications.
As part of the commercialization process, Ilika and its strategic manufacturing partner, Cirtec Medical Corp, will actively gather feedback from this initial customer group. The insights gained will be used to verify customer experience and performance expectations before scaling up production.
This latest milestone advances the 10-year manufacturing agreement signed in August 2023, under which Cirtec Medical, a leading US-based medical device manufacturer, will produce Ilika’s full Stereax battery portfolio. The commencement of prototype shipments represents a key step toward broader commercial deployment of Ilika’s solid-state battery technology in medical markets.
#proactiveinvestors #ilika #aim #ika #goliathautomatedline #SolidStateBatteries #Stereax #GoliathBattery #BatteryTech #GraemePurdy #EVBatteries #EnergyStorage #CirtecMedical #JaguarLandRover #UniversityOfOxford #ProactiveInvestors
